Better Health for All

SAMARA ASSET GRP is a holding company whose principal goods and services are investments and real estate management.

While 34% of its gross asset value is invested in healthcare and biotechnology, this represents an investment focus rather than the direct health impact of the company's own products or services. Therefore, for KPIs related to direct health impact, product safety, pricing, accessibility, risk transparency, R&D, externalities, equity programs, workforce support, preventative measures, data responsibility, crisis response, mental health, patents, nutrition, education, addiction, and clinical trials, the company's direct operations are not applicable, resulting in a neutral score of 0 for these categories. No evidence was found regarding harmful revenue share.

Fair Pay & Worker Respect

No specific data points were found across the provided articles for any of the KPIs related to Fair Pay & Worker Respect for SRAG.XETRA. Information regarding living wage coverage, CEO-to-median pay ratio, collective bargaining share, safety incident rate, pay equity ratio, worker engagement score, turnover rate, labor violation incidents, insecure contract share, or health insurance coverage was not available.

While one article mentioned staff expenses of EUR 0.4m for SRAG.XETRA, this financial figure does not provide sufficient detail to score any specific KPI.

Fair Trade & Ethical Sourcing

No specific, concrete data points were found in the provided articles regarding SAMARA ASSET GRP's performance on any of the Fair Trade & Ethical Sourcing KPIs. The articles primarily discuss general sustainability trends in the German real estate market

, ESG factors in investment , or focus on other companies like ZAR Real Estate , without providing actionable evidence for SRAG.XETRA's supply chain practices, certifications, or incident records.

Honest & Fair Business

No specific, concrete data points were found in the provided articles to assess Samara Asset Group PLC against the 'Honest & Fair Business' ethical value. The Euronext Admission Document explicitly states that no ESG or ethical compliance metrics were provided.

Other articles consist of a security alert regarding fraudulent impersonation of the company and privacy policies, none of which contain information relevant to regulatory fines, transparency benchmarks, whistleblower policies, financial restatements, audit coverage, ESG controversies, complaint resolution times, board independence, anti-corruption policies, or third-party verification of ethical claims.

Kind to Animals

SAMARA ASSET GRP (SRAG.XETRA) is described as a holding company focused on real estate. The provided articles primarily discuss Samara Capital, an investment firm, and its portfolio companies which operate in sectors such as personal care, retail, and food.

There is no explicit evidence linking Samara Capital or its portfolio companies directly to SRAG.XETRA. Therefore, no specific, quantifiable data points related to animal welfare practices, policies, or impacts of SRAG.XETRA could be identified in the provided materials.

No War, No Weapons

Samara Capital's Responsible Investment Policy, last updated in May 2023,

includes an exclusion criterion for knowingly investing in any entity involved in the direct manufacturing, selling, or distribution of controversial weapons (nuclear, chemical, or biological weapons). This policy acts as ethical red lines for the company. The company will not knowingly invest in such entities, which implies a formal divestment policy with immediate effect on new conflict exposures. However, the policy only covers specific controversial weapons, not all categories of conventional arms. The company aligns with the UN Guiding Principles on Business and Human Rights, and its Responsible Investment policy outlines governance controls for ESG integration, but there is no evidence of external verification or published performance metrics. ESG matters are discussed during the board meetings of all portfolio companies, and progress against ESG metrics is part of the discussion, indicating regular board review of defense exposure. The company conducts periodic independent ESG reviews of its portfolio companies, but the frequency is not specified beyond 'periodic', which is less than a single assessment in the last three years.

Zero Waste & Sustainable Products

Sapphire Foods, a portfolio company, uses 100% paper-based, FSC-certified packaging.

More Retail reduced single-use plastic by 19%. Several waste reduction initiatives are in place across portfolio companies, including More Retail reducing food waste by approximately 100 tons, FirstMeridian reducing paper consumption by about 70%, Paradise reducing solid fuel consumption by 25%, Sapphire Foods recycling used cooking oil, and SMT and Sekhmet Pharma having zero liquid discharge systems. Sekhmet Pharma manages hazardous waste according to local laws, and SMT has a comprehensive waste management plan. More Retail, Esme Consumer, and Marengo Asia Hospitals have ESG roadmaps and targets for 2025 and 2030. Sapphire Foods has supplier agreements covering ethically sourced materials and sustainability policies. More Retail has implemented behavioral interventions to encourage customers to reduce packaging. More Retail conducts detailed safety audits of facilities quarterly and annually, and Marengo Asia Hospitals has an exhaustive waste management plan.